UBS Group’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-47,000
Closed -$578K 10197
2021
Q4
$578K Sell
47,000
-9,800
-17% -$173K ﹤0.01% 4850
2021
Q3
$1.04M Sell
56,800
-263,700
-82% -$2.91M ﹤0.01% 4172
2021
Q2
$3.58M Buy
+320,500
New +$5.05M ﹤0.01% 3022

Other funds holding AMTX

UBS Group's AMTX Position: Q1 2026 in Review

UBS Group increased its Aemetis (AMTX) stake by 129% in Q1 2026, buying an estimated $183K and bringing the position to 178,950 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #5990.

UBS Group first reported a position in AMTX in Q1 2017 and has held it in 36 quarters since. The position peaked at $1.76M in Q2 2021. 78 funds tracked by Wall St. Rank hold AMTX as of Q1 2026.

  • UBS Group held 178,950 shares of Aemetis worth $571K as of Q1 2026.
  • UBS Group bought 100,706 Aemetis shares in Q1 2026, an estimated $183K.
  • Aemetis made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5990 holding.
  • UBS Group first reported a position in Aemetis in Q1 2017 and has held it in 36 quarters since.
  • UBS Group's Aemetis position peaked at $1.76M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Aemetis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.